Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance (Q34547849)

2 August 2017

1 reference

title

Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance (English)

1 reference

2 August 2017

main subject

antimicrobial resistance

1 reference

K P Klugman

1 reference

2 August 2017

language of work or name

1 reference

1 September 2001

1 reference

Lancet Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

85-91

1 reference

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzas type b conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

The impact of conjugate vaccine on carriage of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Carriage of pneumococci after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Antibody-secreting cells and their relation to humoral antibodies in serum and in nasopharyngeal aspirates in children with pneumococcal acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

Pneumococcal conjugate vaccination for adults: why it's important for children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900063-9

7 January 2021

10.1016/S1473-3099(01)00063-9

Identifiers

DOI

1 reference

2 August 2017

1 reference